ADALAT ® XL ® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to ...

TORONTO--(BUSINESS WIRE)--Today, Juno Pharmaceuticals Canada (“Juno”), a leader in the commercialization of specialty pharmaceuticals, announced the acquisition of Omega Laboratories (“Omega”), one of ...

Princeton-based Sun Pharmaceutical Industries Limited announced the appointment of Jeremy Allen as vice president, corporate ...

--DAYBUE is the first and only therapy approved in Canada for the treatment of Rett syndrome, a rare, neurodevelopmental disorder SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) ...

TORONTO, Oct. 9, 2025 /PRNewswire/ - Does Canada pay a fair share of the global cost of pharmaceutical innovation? Are the prices for patented medicines threatening the sustainability of public drug ...

ARS Pharmaceuticals, Inc. has announced the filing for approval of neffy® (epinephrine nasal spray) 2 mg in Canada and the United Kingdom, where it will be marketed as EURneffy®. This follows neffy's ...

TORONTO, Oct. 23, 2025 /CNW/ - Apotex Inc. ("Apotex" or the "Company"), the largest Canadian-based pharmaceutical company, today announced that Health Canada has granted a Notice of Compliance (NOC) f ...

This investment will help build a 103,000-square-foot R&D center and a GMP manufacturing facility in Edmonton, Alberta. The biomanufacturing facility will develop and produce the Entos Fusogenix PLV ...

CORAL GABLES, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, ...

Entos® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures, has announced a $62 million investment from the ...

Ottawa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The global Canada pharmaceutical packaging market hit USD 7.53 billion in 2025, with current forecasts pointing to USD 14.43 billion by 2034, according to ...